Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2025-12-24 @ 4:26 PM
NCT ID:
NCT05346666
Eligibility Criteria:
Inclusion Criteria:
* Age: 15-75 years old.
* Gender: Male and female.
* Newly diagnosed refractory status epilepticus patients who are scheduled to receive anti-epileptic drugs.
* Patients with normal renal and hematological functions.
Exclusion Criteria:
* Old age \>75 years old.
* Pregnant or lactating females.
* Severe renal impairment when GFR\<30 ml/min.
* Hepatic patients ( not recommended with active hepatic disease or hepatic impairment specially when ALT or AST \>3 times ULN).
* Neutropenia when neutrophil count \<500 cells/mm3 due to increase the risk of infection.
* Thrombocytopenia when platelet count \< 50000 cells/mm3.
* Patients take Immunosuppressant drugs.
* Cancer patient who taking chemotherapy.
* Patients with a known hypersensitivity to any of the used drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
75 Years
Study:
NCT05346666
Study Brief:
Protocol Section:
NCT05346666